CVRx, Inc. (CVRX) is a Medical - Devices company in the Healthcare sector, currently trading at $7.72. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is CVRX = $12 (+49% upside).
Valuation: CVRX trades at a trailing Price-to-Earnings (P/E) of -3.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.31.
Financials: revenue is $57M, +38.6%/yr average growth. Net income is $53M (loss), growing at -11.3%/yr. Net profit margin is -94.1% (negative). Gross margin is 85.3% (+7.5 pp trend).
Balance sheet: total debt is $51M against $39M equity (Debt-to-Equity (D/E) ratio 1.29, moderate). Current ratio is 7.63 (strong liquidity). Debt-to-assets is 48.5%. Total assets: $105M.
Analyst outlook: 6 / 7 analysts rate CVRX as buy (86%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 79/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 50/100 (Partial), Future 94/100 (Pass), Income 10/100 (Fail).
